- Home
- AUPH vs AVAH Comparison
AUPH vs AVAH Comparison
Compare AUPH & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- AVAH
- Stock Information
- Founded
- AUPH 1993
- AVAH 1984
- Country
- AUPH Canada
- AVAH United States
- Employees
- AUPH N/A
- AVAH N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- AVAH Hospital/Nursing Management
- Sector
- AUPH Health Care
- AVAH Health Care
- Exchange
- AUPH Nasdaq
- AVAH Nasdaq
- Market Cap
- AUPH 1.0B
- AVAH 1.1B
- IPO Year
- AUPH 1999
- AVAH 2021
- Fundamental
- Price
- AUPH $8.12
- AVAH $5.57
- Analyst Decision
- AUPH Strong Buy
- AVAH Hold
- Analyst Count
- AUPH 3
- AVAH 4
- Target Price
- AUPH $10.33
- AVAH $4.27
- AVG Volume (30 Days)
- AUPH 1.3M
- AVAH 285.7K
- Earning Date
- AUPH 11-07-2024
- AVAH 11-07-2024
- Dividend Yield
- AUPH N/A
- AVAH N/A
- EPS Growth
- AUPH N/A
- AVAH N/A
- EPS
- AUPH N/A
- AVAH N/A
- Revenue
- AUPH $220,361,000.00
- AVAH $1,983,475,000.00
- Revenue This Year
- AUPH $36.52
- AVAH $7.43
- Revenue Next Year
- AUPH $19.02
- AVAH $5.06
- P/E Ratio
- AUPH N/A
- AVAH N/A
- Revenue Growth
- AUPH 38.72
- AVAH 6.21
- 52 Week Low
- AUPH $4.71
- AVAH $1.88
- 52 Week High
- AUPH $10.05
- AVAH $6.19
- Technical
- Relative Strength Index (RSI)
- AUPH 62.64
- AVAH 58.05
- Support Level
- AUPH $8.06
- AVAH $5.72
- Resistance Level
- AUPH $8.70
- AVAH $6.19
- Average True Range (ATR)
- AUPH 0.34
- AVAH 0.30
- MACD
- AUPH 0.07
- AVAH 0.08
- Stochastic Oscillator
- AUPH 63.74
- AVAH 65.93
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.